These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Augmentation of immune defense mechanisms of the lung by romurtide]. Hasegawa J, Satoh A, Yagi K, Chida K. Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):605-11. PubMed ID: 7666614 [Abstract] [Full Text] [Related]
6. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa. Speert DP, Wong SY, Macdonald M, Sargeant R. Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751 [Abstract] [Full Text] [Related]
8. Enhancement of non-specific resistance to Pseudomonas pneumonia by a synthetic derivative of muramoyl dipeptide in immunosuppressed guinea pigs. Osada Y, Ohtani T, Une T, Ogawa H, Nomoto K. J Gen Microbiol; 1982 Oct; 128(10):2361-70. PubMed ID: 7153754 [Abstract] [Full Text] [Related]
10. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production. Shirai R, Kadota J, Tomono K, Ogawa K, Iida K, Kawakami K, Kohno S. Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827 [Abstract] [Full Text] [Related]
11. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Hunninghake GW, Gallin JI, Fauci AS. Am Rev Respir Dis; 1978 Jan; 117(1):15-23. PubMed ID: 619716 [Abstract] [Full Text] [Related]